LUMO Insider Trading Activity and SEC Form 4 Filings
LUMO insider trading summary
No open-market insider purchases or sales of Lumos Pharma, Inc. (LUMO) have been reported on SEC Form 4 in the past 12 months.
Latest LUMO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jan 8, 2021 | Deerfield Mgmt III, L.P. | 10% Owner | Sell | $24K (1,000 @ $24.11) |
| Jan 8, 2021 | Deerfield Mgmt III, L.P. | 10% Owner | Sell | $92K (3,912 @ $23.57) |
| Jan 8, 2021 | Deerfield Private Design Fund III, L.P. | 10% Owner | Sell | $24K (1,000 @ $24.11) |
| Jan 8, 2021 | James E Flynn | 10% Owner | Sell | $24K (1,000 @ $24.11) |
| Jan 8, 2021 | James E Flynn | 10% Owner | Sell | $2.3M (101,600 @ $22.24) |
| Jan 8, 2021 | Deerfield Mgmt III, L.P. | 10% Owner | Sell | $2.3M (101,600 @ $22.24) |
| Jan 8, 2021 | Deerfield Management Company, L.P. (series C) | 10% Owner | Sell | $92K (3,912 @ $23.57) |
| Jan 8, 2021 | James E Flynn | 10% Owner | Sell | $92K (3,912 @ $23.57) |
| Jan 8, 2021 | Deerfield Private Design Fund III, L.P. | 10% Owner | Sell | $92K (3,912 @ $23.57) |
| Jan 8, 2021 | Deerfield Management Company, L.P. (series C) | 10% Owner | Sell | $24K (1,000 @ $24.11) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.